Biomnis SELAS:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Biomnis SELAS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11401
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biomnis SELAS (Biomnis), a subsidiary of Eurofins Scientific SE, is a provider of medical laboratory testing services. The company offers laboratory tests in the areas of generics, biochemistry, immunology, cytogenics, assisted reproductive technology-embrology-sperm science, onco-haemotology, analytical chemistry, genetic fingerprinting, molecular biology, infectiology, and others. It also provides pathological anatomy and cytology test for the treatment and management of cancers and others diseases. PAC laboratory serves its services to various hospital, pharmaceutical companies, and medical biology laboratories. The company has its operations in France, Ireland and the UK. Biomnis is headquartered in Lyon, France.

Biomnis SELAS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biomnis SELAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biomnis SELAS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biomnis SELAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biomnis SELAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Biomnis SELAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biomnis SELAS, Medical Equipment, Deal Details 10
Private Equity 10
Ardian Acquires 95% Stake in Biomnis 10
Partnerships 11
Biomnis SELAS Enters into Agreement with DIATHERIX Laboratories 11
Biomnis Enters into Agreement with ODPM 12
Acquisition 13
Eurofins Scientific Acquires Biomnis for USD250 Million 13
Biomnis SELAS – Key Competitors 14
Biomnis SELAS – Key Employees 15
Biomnis SELAS – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Biomnis SELAS, Medical Equipment, Key Facts 2
Biomnis SELAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Biomnis SELAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biomnis SELAS, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Biomnis SELAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biomnis SELAS, Deals By Market, 2012 to YTD 2018 8
Biomnis SELAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ardian Acquires 95% Stake in Biomnis 10
Biomnis SELAS Enters into Agreement with DIATHERIX Laboratories 11
Biomnis Enters into Agreement with ODPM 12
Eurofins Scientific Acquires Biomnis for USD250 Million 13
Biomnis SELAS, Key Competitors 14
Biomnis SELAS, Key Employees 15
Biomnis SELAS, Subsidiaries 16

List of Figures
Biomnis SELAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Biomnis SELAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Biomnis SELAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Biomnis SELAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Biomnis SELAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Biomnis SELAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Biomnis SELAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Biomnis SELAS, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Biomnis SELAS:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Santee Cooper:企業の戦略的SWOT分析
    Santee Cooper - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Impax Laboratories Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous sy …
  • Affymetrix, Inc.-医療機器分野:企業M&A・提携分析
    Summary Affymetrix, Inc. (Affymetrix) provides life science, and molecular diagnostic products for analysis of biological systems at gene, protein and cellular level. It offers products for two major applications, namely, genotyping and gene expression. Affymetrix offers three families of instrument …
  • Leonardo S.p.A.:企業の戦略・SWOT・財務情報
    Leonardo S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Leonardo S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Kingsbury Plc:企業の戦略・SWOT・財務情報
    The Kingsbury Plc - Strategy, SWOT and Corporate Finance Report Summary The Kingsbury Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Singulus Technologies AG (SNG):電力:M&Aディール及び事業提携情報
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • OncBioMune Pharmaceuticals Inc (OBMP):製薬・医療:M&Aディール及び事業提携情報
    Summary OncBioMune Pharmaceuticals Inc (OncBioMune), formerly Quint Media Inc is a biopharmaceutical company that develops novel cancer immunotherapy products. The company’s products comprise biosimilars and vaccines developed for cancer types such as renal, breast, prostrate, and ovarian cancer. It …
  • Ventas Inc:企業のM&A・事業提携・投資動向
    Ventas Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ventas Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • IFA Hotels and Resorts Company KSCC:企業の戦略・SWOT・財務情報
    IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report Summary IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Landstar System, Inc.:企業の戦略・SWOT・財務分析
    Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • John Keells Hotels Plc
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Southwestern Energy Company:企業の戦略・SWOT・財務情報
    Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report Summary Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Grupo Nacional Provincial, S.A.B.:企業の戦略・SWOT・財務分析
    Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Nacional Provincial, S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, …
  • ERHC Energy Inc (ERHE):企業の財務・戦略的SWOT分析
    Summary ERHC Energy Inc (ERHC Energy) is an exploration and production company that explores oil and gas assets. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republic of Kenya. It holds interests …
  • Lucasfilm Ltd:企業の戦略的SWOT分析
    Lucasfilm Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Aptuit LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aptuit LLC (Aptuit) is a developer and manufacturer of pharmaceutical drug. The company offers drug design and discovery, IND enabling programs, integrated chemistry, manufacture and control and indigo. It drug discovery capabilities includes medicinal chemistry, computational chemistry, pha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆